Indeed, the idea of IGF-II secretion as a rare associated event in cancer has been maintained in the scientific literature till present [29], somehow implying that IGF-II-secreting tumors could be mostly benign in nature and fully surgically treatable. Here, IGF2 is linked to cancer.